-+ 0.00%
-+ 0.00%
-+ 0.00%

William Blair Downgrades Vistagen Therapeutics to Market Perform

Benzinga·12/17/2025 21:17:41
Listen to the news
William Blair analyst Tim Lugo downgrades Vistagen Therapeutics (NASDAQ:VTGN) from Outperform to Market Perform.